NCT07385781 (Psychosomatic) is a clinical trial of Casr in Psychosomatic Symptoms, sponsored by Bahria University.

Who is sponsoring NCT07385781?

NCT07385781 is sponsored by Bahria University.

What drugs are being tested in NCT07385781?

Interventions in NCT07385781: Casr.

What condition does NCT07385781 study?

NCT07385781 studies Psychosomatic Symptoms, Temporomandibular Disorder (TMD).

Is NCT07385781 still recruiting?

NCT07385781 is currently not yet recruiting. Last updated 18 March 2026.

Last reviewed 2026-03-18 · How we verify

NCT07385781: Psychosomatic

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychosomatic Symptoms in Patients With Myofascial Pain and Temporomandibular Joint Dysfunction

Not yet recruiting Last updated 18 March 2026

What this trial tests

trial testing Casr in Psychosomatic Symptoms in 300 participants. Not yet recruiting.

Timeline

1 March 2026

Primary endpoint
30 June 2026

30 August 2026

Quick facts

Lead sponsor	Bahria University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 March 2026
Primary completion	30 June 2026
Estimated completion	30 August 2026
Sites	1 location across Pakistan

Drugs / interventions tested

Casr

Conditions studied

Psychosomatic Symptoms — all drugs for Psychosomatic Symptoms →
Temporomandibular Disorder (TMD) — all drugs for Temporomandibular Disorder (TMD) →

Sponsor

Bahria University

Who can join

Adults 20 to 60, any sex, with Psychosomatic Symptoms or Temporomandibular Disorder (TMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Temporomandibular joint disorder poses an intricate etiology. Biomechanical, neuromuscular and psychosocial factors may contribute to the disorder among which psychological and psychosocial disturbances have shown strong direct or indirect contribution to the disease especially when the pain is of muscular origin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bahria University trials

Trials by the same sponsor.

NCT07379983 — Evaluating the Effectiveness of Print Based Environmental Health Intervention Education Among School Going Adolescents o · NA · not yet recruiting
NCT07255820 — Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol · Phase 4 · not yet recruiting
NCT07452913 — Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes · Phase 4 · enrolling by invitation
NCT07375082 — Rehabilitation Approaches Used in Total Knee Replacement · active not recruiting
NCT07338955 — Validating and Assessing Reliability · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07385781 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bahria University
Last refreshed: 18 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07385781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing